Navigation Links
Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
Date:4/30/2008

CARLSBAD, Calif., April 30 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the company's participation in the Bank of America 2008 Healthcare Conference scheduled to take place at the Four Seasons Hotel in Las Vegas, Nev., May 13 - 15, 2008.

Dr. Tina Nova Bennett, President and CEO of Genoptix, and Sam Riccitelli, COO, will present at the conference on Tuesday, May 13, 2008 beginning at approximately 9:20am PDT. They will provide an overview of the company's specialized diagnostic laboratory service offerings, growth strategies and operational performance.

The presentation is expected to last approximately 40 minutes, followed by a short question and answer session, all of which will be webcast live on the Internet and accessible through the investor relations section of the Genoptix website at http://www.genoptix.com. Listeners should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Actual results may differ materially from those projected. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
2. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
3. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
4. Genoptix Announces Pricing of Secondary Public Offering
5. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
6. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
7. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
8. Genoptix, Inc. Announces Pricing for Initial Public Offering
9. Webcast Alert: Neurocrine Announces 1Q08 Financial Results
10. ATS Medical Announces First Frontiers in Cryoablation Symposium
11. Carriage Services Announces First Quarter Earnings Release and Conference Call Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... weeks Nature’s Tears® EyeMist®, the signature product of her research center at Bio-Logic ... the world’s largest population and the greatest number of sufferers of blindness. “We ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... and application performance monitoring (APM) solutions, has expanded its footprint inside the ... According to Peter Ohrenberger, sales director at Nastel, “We’ve replaced an existing ...
(Date:7/20/2017)... ATLANTA, Ga. (PRWEB) , ... July 20, 2017 , ... ... and equal access to medicine for everyone affected by diabetes, is teaming up with ... the five-day global event kicks off on July 24th. , “Team Type 1’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata ... and boosting quality. , It’s known as the “CY2016 Annual FDA Medical Device ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... 20, 2017  Prime Therapeutics LLC (Prime) released this statement ... following today,s Institute for Clinical and Economic Review,s (ICER) ... effectiveness and value of abuse-deterrent formulations (ADF) of opioids. Prime ... at the meeting. ... benefit to the use of abuse-deterrent formulations (ADF) in opioids ...
(Date:7/15/2017)... 15, 2017 Enterin Inc., a Philadelphia ... disease (PD), today announced the completion of a $12.7 million ... Ventures III, as well as the participation of existing investors. ... to have the support of New Ventures III and our ... validation of the potential of our platform technology to transform ...
(Date:7/13/2017)... 2017  Centurion Medical Products, a leader in medical product innovation ... impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of ... patient pain while preventing unneeded emergency department admission due to severe ...
Breaking Medicine Technology: